2024 heart disease and stroke statistics: a report of US and global data from the American Heart Association

SS Martin, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2024 - Am Heart Assoc
BACKGROUND: The American Heart Association (AHA), in conjunction with the National
Institutes of Health, annually reports the most up-to-date statistics related to heart disease …

Heart disease and stroke statistics—2023 update: a report from the American Heart Association

CW Tsao, AW Aday, ZI Almarzooq, CAM Anderson… - Circulation, 2023 - Am Heart Assoc
Background: The American Heart Association, in conjunction with the National Institutes of
Health, annually reports the most up-to-date statistics related to heart disease, stroke, and …

2020 expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of …

SR Das, BM Everett, KK Birtcher, JM Brown… - Journal of the American …, 2020 - jacc.org
2020 Expert Consensus Decision Pathway on Novel Therapies for Cardiovascular Risk
Reduction in Patients With Type 2 Diabetes: A Report of the American College of …

Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention

ND Wong, N Sattar - Nature Reviews Cardiology, 2023 - nature.com
Cardiovascular diseases (CVDs) are the leading causes of morbidity and mortality in
individuals with type 2 diabetes mellitus (T2DM). Secular changes in CVD outcomes have …

Comprehensive care models for cardiometabolic disease

C Reiter-Brennan, O Dzaye, D Davis, M Blaha… - Current Cardiology …, 2021 - Springer
Abstract Purpose of Review The high burden of cardiovascular disease and the
simultaneous obesity pandemic is placing an extraordinary strain on the health care system …

[HTML][HTML] Diabesity alters the protective effects of estrogens on endothelial function through adipose tissue secretome

MR Martínez-Cignoni, A González-Vicens… - Free Radical Biology …, 2024 - Elsevier
Estrogens have a well-known protective role in the development of the metabolic syndrome.
Nevertheless, recent epidemiological data question the cardioprotective effect of estrogens …

Control of cardiovascular risk factors among US adults with type 2 diabetes with and without cardiovascular disease

R Andary, W Fan, ND Wong - The American Journal of Cardiology, 2019 - Elsevier
Cardiovascular disease (CVD) remains leading cause of death among adults with type 2
diabetes (T2DM). There is a lack of recent national data on attainment of single and multiple …

Cardiovascular benefit of empagliflozin across the spectrum of cardiovascular risk factor control in the EMPA-REG OUTCOME trial

SE Inzucchi, K Khunti, DH Fitchett… - The Journal of …, 2020 - academic.oup.com
Context Control of multiple cardiovascular (CV) risk factors reduces CV events in individuals
with type 2 diabetes. Objective To investigate this association in a contemporary clinical trial …

[HTML][HTML] Rationale, design, and implementation of intensive risk factor treatment in the CREST2 trial

TN Turan, JH Voeks, MI Chimowitz, A Roldan… - Stroke, 2020 - journals.lww.com
Background and Purpose: The CREST2 trial (Carotid Revascularization and Medical
Management for Asymptomatic Carotid Stenosis) is comparing intensive medical …

[HTML][HTML] Detection of cardiac arrhythmia using fuzzy logic

P Kora, K Meenakshi, K Swaraja, A Rajani… - Informatics in Medicine …, 2019 - Elsevier
Background There is recent increasing interest in physical fitness, and improvement in
applications for this purpose have been standout amongst recent research efforts. An …